These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

623 related items for PubMed ID: 15343358

  • 1. Sequential delivery of interferon-alpha gene and DCs to intracranial gliomas promotes an effective antitumor response.
    Tsugawa T, Kuwashima N, Sato H, Fellows-Mayle WK, Dusak JE, Okada K, Papworth GD, Watkins SC, Gambotto A, Yoshida J, Pollack IF, Okada H.
    Gene Ther; 2004 Nov; 11(21):1551-8. PubMed ID: 15343358
    [Abstract] [Full Text] [Related]

  • 2. Effective induction of antiglioma cytotoxic T cells by coadministration of interferon-beta gene vector and dendritic cells.
    Nakahara N, Pollack IF, Storkus WJ, Wakabayashi T, Yoshida J, Okada H.
    Cancer Gene Ther; 2003 Jul; 10(7):549-58. PubMed ID: 12833135
    [Abstract] [Full Text] [Related]

  • 3. Delivery of interferon-alpha transfected dendritic cells into central nervous system tumors enhances the antitumor efficacy of peripheral peptide-based vaccines.
    Okada H, Tsugawa T, Sato H, Kuwashima N, Gambotto A, Okada K, Dusak JE, Fellows-Mayle WK, Papworth GD, Watkins SC, Chambers WH, Potter DM, Storkus WJ, Pollack IF.
    Cancer Res; 2004 Aug 15; 64(16):5830-8. PubMed ID: 15313927
    [Abstract] [Full Text] [Related]

  • 4. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T, Iwahashi M, Nakamura M, Matsuda K, Naka T, Nakamori M, Ueda K, Ishida K, Yamaue H.
    Int J Oncol; 2006 Apr 15; 28(4):947-53. PubMed ID: 16525645
    [Abstract] [Full Text] [Related]

  • 5. Adoptive transfer of type 1 CTL mediates effective anti-central nervous system tumor response: critical roles of IFN-inducible protein-10.
    Nishimura F, Dusak JE, Eguchi J, Zhu X, Gambotto A, Storkus WJ, Okada H.
    Cancer Res; 2006 Apr 15; 66(8):4478-87. PubMed ID: 16618775
    [Abstract] [Full Text] [Related]

  • 6. Dendritic cell therapy with interferon-alpha synergistically suppresses outgrowth of established tumors in a murine colorectal cancer model.
    Ishii S, Hiroishi K, Eguchi J, Hiraide A, Imawari M.
    Gene Ther; 2006 Jan 15; 13(1):78-87. PubMed ID: 16107857
    [Abstract] [Full Text] [Related]

  • 7. Interferon-alpha gene therapy in combination with CD80 transduction reduces tumorigenicity and growth of established tumor in poorly immunogenic tumor models.
    Hiroishi K, Tüting T, Tahara H, Lotze MT.
    Gene Ther; 1999 Dec 15; 6(12):1988-94. PubMed ID: 10637450
    [Abstract] [Full Text] [Related]

  • 8. Intratumoral delivery of dendritic cells engineered to secrete both interleukin (IL)-12 and IL-18 effectively treats local and distant disease in association with broadly reactive Tc1-type immunity.
    Tatsumi T, Huang J, Gooding WE, Gambotto A, Robbins PD, Vujanovic NL, Alber SM, Watkins SC, Okada H, Storkus WJ.
    Cancer Res; 2003 Oct 01; 63(19):6378-86. PubMed ID: 14559827
    [Abstract] [Full Text] [Related]

  • 9. Induction of potent antitumor immunity by intratumoral injection of interleukin 23-transduced dendritic cells.
    Hu J, Yuan X, Belladonna ML, Ong JM, Wachsmann-Hogiu S, Farkas DL, Black KL, Yu JS.
    Cancer Res; 2006 Sep 01; 66(17):8887-96. PubMed ID: 16951206
    [Abstract] [Full Text] [Related]

  • 10. In vitro activation of cancer patient-derived dendritic cells by tumor cells genetically modified to express CD154.
    Loskog A, Tötterman TH, Böhle A, Brandau S.
    Cancer Gene Ther; 2002 Oct 01; 9(10):846-53. PubMed ID: 12224026
    [Abstract] [Full Text] [Related]

  • 11. Injection of IL-12 gene-transduced dendritic cells into mouse liver tumor lesions activates both innate and acquired immunity.
    Tatsumi T, Takehara T, Yamaguchi S, Sasakawa A, Miyagi T, Jinushi M, Sakamori R, Kohga K, Uemura A, Ohkawa K, Storkus WJ, Hayashi N.
    Gene Ther; 2007 Jun 01; 14(11):863-71. PubMed ID: 17344900
    [Abstract] [Full Text] [Related]

  • 12. Induction of antitumor immunity with dendritic cells transduced with adenovirus vector-encoding endogenous tumor-associated antigens.
    Kaplan JM, Yu Q, Piraino ST, Pennington SE, Shankara S, Woodworth LA, Roberts BL.
    J Immunol; 1999 Jul 15; 163(2):699-707. PubMed ID: 10395660
    [Abstract] [Full Text] [Related]

  • 13. Tumor regression induced by intratumor administration of adenovirus vector expressing CD40 ligand and naive dendritic cells.
    Kikuchi T, Miyazawa N, Moore MA, Crystal RG.
    Cancer Res; 2000 Nov 15; 60(22):6391-5. PubMed ID: 11103803
    [Abstract] [Full Text] [Related]

  • 14. Therapeutic and specific antitumor immunity induced by co-administration of immature dendritic cells and adenoviral vector expressing biologically active IL-18.
    Tanaka F, Hashimoto W, Robbins PD, Lotze MT, Tahara H.
    Gene Ther; 2002 Nov 15; 9(21):1480-6. PubMed ID: 12378411
    [Abstract] [Full Text] [Related]

  • 15. Antitumor effect of intratumoral administration of bone marrow-derived dendritic cells transduced with wild-type p53 gene.
    Murakami T, Tokunaga N, Waku T, Gomi S, Kagawa S, Tanaka N, Fujiwara T.
    Clin Cancer Res; 2004 Jun 01; 10(11):3871-80. PubMed ID: 15173096
    [Abstract] [Full Text] [Related]

  • 16. Strategies for antigen loading of dendritic cells to enhance the antitumor immune response.
    Strome SE, Voss S, Wilcox R, Wakefield TL, Tamada K, Flies D, Chapoval A, Lu J, Kasperbauer JL, Padley D, Vile R, Gastineau D, Wettstein P, Chen L.
    Cancer Res; 2002 Mar 15; 62(6):1884-9. PubMed ID: 11912169
    [Abstract] [Full Text] [Related]

  • 17. Interleukin-23-expressing bone marrow-derived neural stem-like cells exhibit antitumor activity against intracranial glioma.
    Yuan X, Hu J, Belladonna ML, Black KL, Yu JS.
    Cancer Res; 2006 Mar 01; 66(5):2630-8. PubMed ID: 16510582
    [Abstract] [Full Text] [Related]

  • 18. Macrophage-derived chemokine gene transfer results in tumor regression in murine lung carcinoma model through efficient induction of antitumor immunity.
    Guo J, Wang B, Zhang M, Chen T, Yu Y, Regulier E, Homann HE, Qin Z, Ju DW, Cao X.
    Gene Ther; 2002 Jun 01; 9(12):793-803. PubMed ID: 12040461
    [Abstract] [Full Text] [Related]

  • 19. Persistent, antigen-specific, therapeutic antitumor immunity by dendritic cells genetically modified with an adenoviral vector to express a model tumor antigen.
    Song W, Tong Y, Carpenter H, Kong HL, Crystal RG.
    Gene Ther; 2000 Dec 01; 7(24):2080-6. PubMed ID: 11223988
    [Abstract] [Full Text] [Related]

  • 20. Interferon gamma stimulates cellular maturation of dendritic cell line DC2.4 leading to induction of efficient cytotoxic T cell responses and antitumor immunity.
    He T, Tang C, Xu S, Moyana T, Xiang J.
    Cell Mol Immunol; 2007 Apr 01; 4(2):105-11. PubMed ID: 17484804
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.